TV networks are bracing for possible new rules and laws with regard to healthcare/pharmaceutical TV advertising. But there might be more to come. Estimates from Emarketer say pharma TV advertising ...
Direct-to-consumer pharmaceutical advertising is under increasing political pressure, with bipartisan legislation being ...
Legal and regulatory experts expect the FDA’s new DTC ad crackdown to face legal challenges. While the FDA’s letters to drugmakers were unprecedented, it may be difficult for the agency to actually ...
More than 90% of doctors said pharma advertising improves patient condition awareness and proactive health management, according to a recent study. IPG Mediabrands’ media intelligence and investment ...
Magna and DeepIntent identified patient-focused messaging and representation as ways companies can build trust. (Marco_Piunti/Getty Images) A survey of more than 2,000 patients and physicians has ...
The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 ...
Pharmaceutical ads now account for 9% of TV advertising according to LightShed Partner’s Richard Greenfield and an even higher percentage of spots on evening newscasts When you purchase through links ...
Ahead of the upfront market, one major issue that seemingly has quieted down is pharmaceutical advertising. Still, things could change once the TV season gets going. Heading into the market, there was ...
The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 ...
Health care and life sciences have long lagged in digital advertising, still focused on mass-audience approaches. But as the blockbuster drug era fades and precision medicine rises, broad strategies ...
The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results